BON Announces Reciept of Nasdaq Compliance Letter
Bon Natural Life (Nasdaq: BON), a bio-ingredient solutions provider for natural health and personal care industries, has received confirmation of compliance with Nasdaq's listing requirements. The company has successfully regained compliance with Listing Rule 5550(a)(2), known as the Bid Price Rule, as confirmed by the Nasdaq Hearings Panel on July 11, 2025.
Following this development, on July 29, 2025, Nasdaq officially closed the matter. However, BON will remain under a one-year Discretionary Panel Monitor to ensure continued compliance.
Bon Natural Life (Nasdaq: BON), fornitore di soluzioni bio-ingredienti per i settori della salute naturale e della cura personale, ha ricevuto la conferma della conformit脿 ai requisiti di quotazione di Nasdaq. La societ脿 ha riconquistato con successo la conformit脿 alla Regola di Quotazione 5550(a)(2), nota come Regola del Prezzo di Offerta, come confermato dal Nasdaq Hearings Panel l'11 luglio 2025.
A seguito di questo sviluppo, il 29 luglio 2025, Nasdaq ha ufficialmente chiuso la questione. Tuttavia, BON rimarr脿 soggetta a un Monitoraggio Discrezionale del Panel per un anno per garantire la conformit脿 continua.
Bon Natural Life (Nasdaq: BON), proveedor de soluciones bioingredientes para las industrias de salud natural y cuidado personal, ha recibido la confirmaci贸n de cumplimiento con los requisitos de cotizaci贸n de Nasdaq. La compa帽铆a ha recuperado con 茅xito el cumplimiento con la Regla de Listado 5550(a)(2), conocida como la Regla del Precio de Oferta, seg煤n lo confirmado por el Panel de Audiencias de Nasdaq el 11 de julio de 2025.
Tras este desarrollo, el 29 de julio de 2025, Nasdaq cerr贸 oficialmente el asunto. Sin embargo, BON permanecer谩 bajo un Monitor Discrecional del Panel por un a帽o para asegurar el cumplimiento continuo.
Bon Natural Life (Nasdaq: BON)鞚� 觳滌棸 瓯搓皶 氚� 臧滌澑 甏�毽� 靷办梾鞚� 鞙勴暅 氚旍澊鞓� 靹彪秳 靻旊（靺� 鞝滉车鞐呾泊搿滌劀, Nasdaq 靸侅灔 鞖旉贝 欷�靾橂ゼ 頇曥澑氚涭晿鞀惦媹雼�. 須岇偓電� 2025雲� 7鞗� 11鞚� Nasdaq 觳 韺剱鞚� 頇曥澑頃� 鞛呾鞍臧� 攴滌箼鞙茧 鞎岆牑歆� 靸侅灔 攴滌箼 5550(a)(2)毳� 靹标车鞝侅溂搿� 須岆车頄堨姷雼堧嫟.
鞚错泟 2025雲� 7鞗� 29鞚� Nasdaq電� 鞚� 瓯挫潉 瓿奠嫕鞝侅溂搿� 膦呺頄堨溂雮�, BON鞚� 歆�靻嶌爜鞚� 欷�靾橂ゼ 氤挫灔頃橁赴 鞙勴暣 1雲勱皠 鞛焿 韺剱 氇媹韯� 雽�靸侅棎 雮矊 霅╇媹雼�.
Bon Natural Life (Nasdaq : BON), fournisseur de solutions bio-ingr茅dients pour les industries de la sant茅 naturelle et des soins personnels, a re莽u la confirmation de sa conformit茅 aux exigences de cotation du Nasdaq. La soci茅t茅 a r茅ussi 脿 retrouver la conformit茅 avec la R猫gle de Cotation 5550(a)(2), connue sous le nom de R猫gle du Prix d'Offre, comme confirm茅 par le Nasdaq Hearings Panel le 11 juillet 2025.
Suite 脿 cette 茅volution, le 29 juillet 2025, le Nasdaq a officiellement clos le dossier. Cependant, BON restera sous un contr么le discr茅tionnaire du panel pendant un an pour garantir le respect continu des r猫gles.
Bon Natural Life (Nasdaq: BON), ein Anbieter von Bio-Zutatenl枚sungen f眉r die Naturgesundheits- und K枚rperpflegeindustrie, hat die Best盲tigung erhalten, dass die Anforderungen f眉r die Nasdaq-Notierung erf眉llt sind. Das Unternehmen hat die Einhaltung der Listing-Regel 5550(a)(2), bekannt als Gebotspreisregel, erfolgreich wiedererlangt, wie vom Nasdaq Hearings Panel am 11. Juli 2025 best盲tigt wurde.
Nach dieser Entwicklung hat Nasdaq die Angelegenheit am 29. Juli 2025 offiziell abgeschlossen. BON bleibt jedoch f眉r ein einj盲hriges diskretion盲res Panel-Monitoring unter Beobachtung, um die fortlaufende Einhaltung sicherzustellen.
- Regained compliance with Nasdaq listing requirements
- Matter officially closed by Nasdaq
- Maintains Nasdaq listing status
- Company will be subject to one-year Discretionary Panel Monitor
As previously reported on a Form 6-K filed with the
On July 29, 2025, the Company received notification from The Nasdaq Stock Market LLC confirming the Panel's decision and stating that the matter is now closed.
About Bon Natural Life Limited ("BON")
BON is a
For more information, please contact:
Cindy Liu | IR 听
Email: [email protected]听
Safe Harbor Statement
This press release contains certain statements that may include "forward-looking statements." All statements other than statements of historical fact included herein are "forward-looking statements." These forward-looking statements are often identified by the use of forward-looking terminology such as "believes,""expects" or similar expressions, involve known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, they do involve assumptions, risks, and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company's periodic reports that are filed with the Securities and Exchange Commission and available on its website ().听 All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, the Company does not assume a duty to update these forward-looking statements.
View original content:
SOURCE Bon Natural Life Limited
FAQ
What did Bon Natural Life (BON) announce regarding Nasdaq compliance in August 2025?
What is the Nasdaq Bid Price Rule that BON had to comply with?
Will BON face any additional monitoring after regaining Nasdaq compliance?
When did BON initially report regaining Nasdaq compliance?
